Pemphigus foliaceus

Current Directions in Autoimmunity

Volumn 10, Issue , 2008, Pages 182-194

  Dasher, D ^a   Rubenstein, D ^a   Diaz, L ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DESMOGLEIN 1; IMMUNOGLOBULIN G;

ANIMAL; BLISTER; CELL ADHESION; HUMAN; IMMUNOLOGY; KERATINOCYTE; PATHOLOGY; PEMPHIGUS; REVIEW;

ANIMALS; AUTOANTIBODIES; BLISTER; CELL ADHESION; DESMOGLEIN 1; HUMANS; IMMUNOGLOBULIN G; KERATINOCYTES; PEMPHIGUS;

EID: 49049087786     PISSN: 14222132     EISSN: 16622936     Source Type: Book Series    
DOI: 10.1159/000131454     Document Type: Review

References (84)

1. Beutner EH, Prigenzi LS, Hale W, Leme Cde A, Bier OG: Immunofluorescent studies of autoantibodies to intercellular areas of epithelia in Brazilian pemphigus foliaceus. Proc Soc Exp Biol Med 1968;127:81-86.
2. Anhalt GJ, Labib RS, Voorhees JJ, Beals TF, Diaz LA: Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med 1982;306:1189-1196.
3. Roscoe JT, Diaz L, Sampaio SA, Castro RM, Labib RS, Takahashi Y, Patel H, Anhalt GJ: Brazilian pemphigus foliaceus autoantibodies are pathogenic to BALB/c mice by passive transfer. J Invest Dermatol 1985;85:538-541.
4. Amagai M, Hashimoto T, Green KJ, Shimizu N, Nishikawa T: Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. J Invest Dermatol 1995;104:895-901.
5. Walker DC, Kolar KA, Hebert AA, Jordon RE: Neonatal pemphigus foliaceus. Arch Dermatol 1995;131:1308-1311.
6. Hirsch R, Anderson J, Weinberg JM, Burnstein P, Echt A, Fermin J, Heilman ER, Laude TA: Neonatal pemphigus foliaceus. J Am Acad Dermatol 2003;49:S187-S189.
7. Wu H, Wang ZH, Fakharzadeh S, Amagai M, Ishikawa H, Uitto J, Stanley JR: Expression of desmoglein 3 in the superficial epidermis of neonatal mice protects against blisters induced by pemphigus foliaceous antibodies. J Invest Dermatol 2000;114:778.
8. Mahoney MG, Wang Z, Rothenberger K, Koch PJ, Amagai M, Stanley JR: Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest 1999;103:461-468.
9. Hanakawa Y, Matsuyoshi N, Stanley JR: Expression of desmoglein 1 compensates for genetic loss of desmoglein 3 in keratinocyte adhesion. J Invest Dermatol 2002;119:27-31.
10. Nagasaka T, Nishifuji K, Ota T, Whittock NV, Amagai M: Defining the pathogenic involvement of desmoglein 4 in pemphigus and staphylococcal scalded skin syndrome. J Clin Invest 2004;114:1484-1492.
11. Evangelista F, Dasher DA, Diaz LA, Li N: The prevalence of autoantibodies against E-cadherin in pemphigus. J Invest Dermatol 2006;126:S9.
12. Robledo MA, Prada S, Jaramillo D, Leon W: South American pemphigus foliaceus: study of an epidemic in El Bagre and Nechi, Colombia 1982 to 1986. Br J Dermatol 1988;118:737-744.
13. Heimgartner E, De Heimagartner V: Experience with endemic dermatological diseases in the Peruvian wilderness: mucocutaneous leishmaniasis and Brazilian foliaceous pemphigus. Med Cutan Ibero Lat Am 1976;4:1-6.
14. Morini JP, Jomaa B, Gorgi Y, Saguem MH, Nouira R, Roujeau JC, Revuz J: Pemphigus foliaceus in young women: an endemic focus in the Sousse area of Tunisia. Arch Dermatol 1993;129:69-73.
15. Hans-Filho G, dos Santos V, Katayama JH, Aoki V, Rivitti EA, Sampaio SA, Friedman H, Moraes JR, Moraes ME, Eaton DP, et al: An active focus of high prevalence of fogo selvagem on an Amerindian reservation in Brazil. Cooperative Group on Fogo Selvagem Research. J Invest Dermatol 1996;107:68-75.
16. Warren SJ, Lin MS, Giudice GJ, Hoffmann RG, Hans-Filho G, Aoki V, Rivitti EA, Santos V, Diaz LA: The prevalence of antibodies against desmoglein 1 in endemic pemphigus foliaceus in Brazil. Cooperative Group on Fogo Selvagem Research. N Engl J Med 2000;343:23-30.
17. Warren SJ, Arteaga LA, Rivitti EA, Aoki V, Hans-Filho G, Qaqish BF, Lin MS, Giudice GJ, Diaz LA: The role of subclass switching in the pathogenesis of endemic pemphigus foliaceus. J Invest Dermatol 2003;120:104-108.
18. Li N, Aoki V, Hans-Filho G, Rivitti EA, Diaz LA: The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem). J Exp Med 2003;197:1501-1510.
19. Moraes ME, Fernandez-Vina M, Lazaro A, Diaz LA, Filho GH, Friedman H, Rivitti E, Aoki V, Stastny P, Moraes JR: An epitope in the third hypervariable region of the DRB1 gene is involved in the susceptibility to endemic pemphigus foliaceus (fogo selvagem) in three different Brazilian populations. Tissue Antigens 1997;49:35-40.
20. Lin MS, Fu CL, Aoki V, Hans-Filho G, Rivitti EA, Moraes JR, Moraes ME, Lazaro AM, Giudice GJ, Stastny P, et al: Desmoglein-1-specific T lymphocytes from patients with endemic pemphigus foliaceus (fogo selvagem). J Clin Invest 2000;105:207-213.
21. Arteaga LA, Prisayanh PS, Warren SJ, Liu Z, Diaz LA, Lin MS: A subset of pemphigus foliaceus patients exhibits pathogenic autoantibodies against both desmoglein-1 and desmoglein-3. J Invest Dermatol 2002;118:806-811.
22. Hilario-Vargas J, Dasher DA, Li N, Aoki V, Hans-Filho G, dos Santos V, Qaqish BF, Rivitti EA, Diaz LA: Prevalence of anti-desmoglein-3 antibodies in endemic regions of fogo selvagem in Brazil. J Invest Dermatol 2006;126:2044-2048.
23. Empinotti JC, Diaz LA, Martins CR, Rivitti EA, Sampaio SA, Lombardi C, Sanches JA: Endemic pemphigus foliaceus in western Parana, Brazil (1976-1988). Cooperative Group for Fogo Selvagem Research. Br J Dermatol 1990;123:431-437.
24. Lombardi C, Borges PC, Chaul A, Sampaio SA, Rivitti EA, Friedman H, Martins CR, Sanches JA Jr, Cunha PR, Hoffmann RG, et al: Environmental risk factors in endemic pemphigus foliaceus (Fogo selvagem). Cooperative Group on Fogo Selvagem Research. J Invest Dermatol 1992;98:847-850.
25. Aoki V, Millikan RC, Rivitti EA, Hans-Filho G, Eaton DP, Warren SJ, Li N, Hilario-Vargas J, Hoffmann RG, Diaz LA: Environmental risk factors in endemic pemphigus foliaceus (fogo selvagem). J Invest Dermatol Symp Proc 2004;9:34-40.
26. Diaz LA, Arteaga LA, Hilario-Vargas J, Valenzuela JG, Li N, Warren S, Aoki V, Hans-Filho G, Eaton D, dos Santos V, et al: Anti-desmoglein-1 antibodies in onchocerciasis, leishmaniasis and Chagas disease suggest a possible etiological link to fogo selvagem. J Invest Dermatol 2004;123:1045-1051.
27. Shimizu A, Ishiko A, Ota T, Tsunoda K, Amagai M, Nishikawa T: IgG binds to desmoglein 3 in desmosomes and causes a desmosomal split without keratin retraction in a pemphigus mouse model. J Invest Dermatol 2004;122:1145-1153.
28. Woo TY, Hogan VA, Patel H, Anhalt GJ, Labib RS, Voorhees JJ, Diaz LA: Specificity and inhibition of the epidermal cell detachment induced by pemphigus IgG in vitro. J Invest Dermatol 1983;81:115s-121s.
29. Hashinmoto K, Shafran KM, Webber PS, Lazarus GS, Singer KH: Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. J Exp Med 1983;157:259-272.
30. Anhalt GJ, Till GO, Diaz LA, Labib RS, Patel HP, Eaglstein NF: Defining the role of complement in experimental pemphigus vulgaris in mice. J Immunol 1986;137:2835-2840.
31. Seishima M, Esaki C, Osada K, Mori S, Hashimoto T, Kitajima Y: Pemphigus IgG, but not bullous pemphigoid IgG, causes a transient increase in intracellular calcium and inositol 1,4,5-triphosphate in DJM-1 cells, a squamous cell carcinoma line. J Invest Dermatol 1995;104:33-37.
32. Esaki C, Seishima M, Yamada T, Osada K, Kitajima Y: Pharmacologic evidence for involvement of phospholipase C in pemphigus IgG-induced inositol 1,4,5-trisphosphate generation, intracellular calcium increase, and plasminogen activator secretion in DJM-1 cells, a squamous cell carcinoma line. J Invest Dermatol 1995;105:329-333.
33. Osada K, Seishima M, Kitajima Y: Pemphigus IgG activates and translocates protein kinase C from the cytosol to the particulate/cytoskeleton fractions in human keratinocytes. J Invest Dermatol 1997;108:482-487.
34. Aoyama Y, Owada MK, Kitajima Y: A pathogenic autoantibody, pemphigus vulgaris-IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes. Eur J Immunol 1999;29:2233-2240.
35. Caldelari R, de Bruin A, Baumann D, Suter MM, Bierkamp C, Balmer V, Muller E: A central role for the armadillo protein plakoglobin in the autoimmune disease pemphigus vulgaris. J Cell Biol 2001;153:823-834.
36. Nguyen VT, Ndoye A, Shultz LD, Pittelkow MR, Grando SA: Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions. J Clin Invest 2000;106:1467-1479.
37. Nguyen VT, Arredondo J, Chernyavsky AI, Kitajima Y, Pittelkow M, Grando SA: Pemphigus vulgaris IgG and methylprednisolone exhibit reciprocal effects on keratinocytes. J Biol Chem 2004;279:2135-2146.
38. Berkowitz P, Hu P, Liu Z, Diaz LA, Enghild JJ, Chua MP, Rubenstein DS: Desmosome Signaling: Inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization. J Biol Chem 2005;280:23778-23784.
39. Aoyama Y, Kitajima Y: Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3 (Dsg3) from the Triton X-100 soluble pools, leading to the formation of Dsg3-depleted desmosomes in a human squamous carcinoma cell line, DJM-1 cells. J Invest Dermatol 1999;112:67-71.
40. Calkins CC, Setzer SV, Jennings JM, Summers S, Tsunoda K, Amagai M, Kowalczyk AP: Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies. J Biol Chem 2006;281:7623-7634.
41. Berkowitz P, Hu P, Prisayanh PS, Diaz LA, Rubenstein DS: Desmoglein-3 trafficking through keratinocyte desmosomes suggests dynamic instability: a kinetic model for PV IgG acantholysis. J Invest Dermatol 2005;124:A28.
42. Wang X, Bregegere F, Frusic-Zlotkin M, Feinmesser M, Michel B, Milner Y: Possible apoptotic mechanism in epidermal cell acantholysis induced by pemphigus vulgaris autoimmunoglobulins. Apoptosis 2004;9:131-143.
43. Wang X, Bregegere F, Soroka Y, Frusic-Zlotkin M, Milner Y: Replicative senescence enhances apoptosis induced by pemphigus autoimmune antibodies in human keratinocytes. FEBS Lett 2004;567:281-286.
44. Pelacho B, Natal C, Espana A, Sanchez-Carpintero I, Iraburu MJ, Lopez-Zabalza MJ: Pemphigus vulgaris autoantibodies induce apoptosis in HaCaT keratinocytes. FEBS Lett 2004;566:6-10.
45. Gniadecki R, Jemec GB, Thomsen BM, Hansen M: Relationship between keratinocyte adhesion and death: anoikis in acantholytic diseases. Arch Dermatol Res 1998;290:528-532.
46. Amagai M, Klaus-Kovtun V, Stanley JR: Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 1991;67:869-877.
47. Eyre RW, Stanley JR: Human autoantibodies against a desmosomal protein complex with a calcium-sensitive epitope are characteristic of pemphigus foliaceus patients. J Exp Med 1987;165:1719-1724.
48. Eyre RW, Stanley JR: Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen. J Clin Invest 1988;81:807-812.
49. Waschke J, Bruggeman P, Baumgartner W, Zillikens D, Drenckhahn D: Pemphigus foliaceus IgG causes dissociation of desmoglein 1-containing junctions without blocking desmoglein 1 transinteraction. J Clin Invest 2005;115:3157-3165.
50. Liu Z, Diaz LA, Troy JL, Taylor AF, Emery DJ, Fairley JA, Giudice GJ: A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest 1993;92:2480-2488.
51. Giudice GJ, Liu Z, Diaz LA: An animal model of bullous pemphigoid: what can it teach us? Proc Assoc Am Physicians 1995;107:237-241.
52. Giudice GJ, Emery DJ, Zelickson BD, Anhalt GJ, Liu Z, Diaz LA: Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain. J Immunol 1993;151:5742-5750.
53. Liu Z, Diaz LA, Swartz SJ, Troy JL, Fairley JA, Giudice GJ: Molecular mapping of a pathogenically relevant BP180 epitope associated with experimentally induced murine bullous pemphigoid. J Immunol 1995;155:5449-5454.
54. Liu Z, Giudice GJ, Swartz SJ, Fairley JA, Till GO, Troy JL, Diaz LA: The role of complement in experimental bullous pemphigoid. J Clin Invest 1995;95:1539-1544.
55. Chen R, Ning G, Zhao ML, Fleming MG, Diaz LA, Werb Z, Liu Z: Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J Clin Invest 2001;108:1151-1158.
56. Liu Z, Giudice GJ, Zhou X, Swartz SJ, Troy JL, Fairley JA, Till GO, Diaz LA: A major role for neutrophils in experimental bullous pemphigoid. J Clin Invest 1997;100:1256-1263.
57. Hu P, Xiao H, Lin MS, Rubenstein DS, O'Keefe EJ, Jennette JC, Diaz LA, Liu Z: Myeloperoxidase-deficient mice are resistant to experimental bullous pemphigoid. J Invest Dermatol 2001;117:442.
58. Chen R, Fairley JA, Zhao ML, Giudice GJ, Zillikens D, Diaz LA, Liu Z: Macrophages, but not T and B lymphocytes, are critical for subepidermal blister formation in experimental bullous pemphigoid: macrophage-mediated neutrophil infiltration depends on mast cell activation. J Immunol 2002;169:3987-3992.
59. Liu Z, Shipley JM, Vu TH, Zhou X, Diaz LA, Werb Z, Senior RM: Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. J Exp Med 1998;188:475-482.
60. Liu Z, Shapiro SD, Zhou X, Twining SS, Senior RM, Giudice GJ, Fairley JA, Diaz LA: A critical role for neutrophil elastase in experimental bullous pemphigoid. J Clin Invest 2000;105:113-123.
61. Amagai M, Matsuyoshi N, Wang ZH, Andl C, Stanley JR: Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. Nat Med 2000;6:1275-1277.
62. Hanakawa Y, Schechter NM, Lin C, Garza L, Li H, Yamaguchi T, Fudaba Y, Nishifuji K, Sugai M, Amagai M, et al: Molecular mechanisms of blister formation in bullous impetigo and staphylococcal scalded skin syndrome. J Clin Invest 2002;110:53-60.
63. Amagai M, Yamaguchi T, Hanakawa Y, Nishifuji K, Sugai M, Stanley JR: Staphylococcal exfoliative toxin B specifically cleaves desmoglein 1. J Invest Dermatol 2002;118:845-850.
64. Mahoney MG, Wang ZH, Stanley JR: Pemphigus vulgaris and pemphigus foliaceus antibodies are pathogenic in plasminogen activator knockout mice. J Invest Dermatol 1999;113:22-25.
65. Mascaro JM Jr, Espana A, Liu Z, Ding X, Swartz SJ, Fairley JA, Diaz LA: Mechanisms of acantholysis in pemphigus vulgaris: role of IgG valence. Clin Immunol Immunopathol 1997;85:90-96.
66. Rock B, Labib RS, Diaz LA: Monovalent Fab' immunoglobulin fragments from endemic pemphigus foliaceus autoantibodies reproduce the human disease in neonatal Balb/c mice. J Clin Invest 1990;85:296-299.
67. Payne AS, Ishii K, Kacir S, Lin C, Li H, Hanakawa Y, Tsunoda K, Amagai M, Stanley JR, Siegel DL: Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display. J Clin Invest 2005;115:888-899.
68. Benndorf R, Hayess K, Ryazantsev S, Wieske M, Behlke J, Lutsch G: Phosphorylation and supramolecular organization of murine small heat shock protein HSP25 abolish its actin polymerization-inhibiting activity. J Biol Chem 1994;269:20780-20784.
69. Geum D, Son GH, Kim K: Phosphorylation-dependent cellular localization and thermoprotective role of heat shock protein 25 in hippocampal progenitor cells. J Biol Chem 2002;277:19913-19921.
70. Panasenko OO, Kim MV, Marston SB, Gusev NB: Interaction of the small heat shock protein with molecular mass 25 kDa (hsp25) with actin. Eur J Biochem 2003;270:892-901.
71. Perng MD, Cairns L, van den IP, Prescott A, Hutcheson AM, Quinlan RA: Intermediate filament interactions can be altered by HSP27 and βB-crystallin. J Cell Sci 1999;112:2099-2112.
72. Evgrafov OV, Mersiyanova I, Irobi J, van Den Bosch L, Dierick I, Leung CL, Schagina O, Verpoorten N, van Impe K, Fedotov V, et al: Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nat Genet 2004;36:602-606.
73. Lavoie JN, Hickey E, Weber LA, Landry J: Modulation of actin microfilament dynamics and fluid phase pinocytosis by phosphorylation of heat shock protein 27. J Biol Chem 1993;268:24210-24214.
74. Lavoie JN, Lambert H, Hickey E, Weber LA, Landry J: Modulation of cellular thermoresistance and actin filament stability accompanies phosphorylation-induced changes in the oligomeric structure of heat shock protein 27. Mol Cell Biol 1995;15:505-516.
75. Guay J, Lambert H, Gingras-Breton G, Lavoie JN, Huot J, Landry J: Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27. J Cell Sci 1997;110:357-368.
76. Bruey JM, Ducasse C, Bonniaud P, Ravagnan L, Susin SA, Diaz-Latoud C, Gurbuxani S, Arrigo AP, Kroemer G, Solary E, et al: Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol 2000;2:645-652.
77. Berkowitz P, Hu P, Warren S, Liu Z, Diaz LA, Rubenstein DS: p38MAPK inhibition prevents disease in pemphigus vulgaris mice. Proc Natl Acad Sci USA 2006;103:12855-12860.
78. Rubenstein DS, Berkowitz P, Hu P, Liu Z, Diaz LA, Enghild JJ, Chua MP: Inhibition of p38MAPK prevents pemphigus vulgaris IgG induced cytoskeleton reorganization. J Invest Dermatol 2005;124:A28.
79. Waschke J, Spindler V, Bruggeman P, Zillikens D, Schmidt G, Drenckhahn D: Inhibition of Rho A activity causes pemphigus skin blistering. J Cell Biol 2006;175:721-727.
80. Lewis JE, Jensen PJ, Wheelock MJ: Cadherin function is required for human keratinocytes to assemble desmosomes and stratify in response to calcium. J Invest Dermatol 1994;102:870-877.
81. Lewis JE, Wahl JK 3rd, Sass KM, Jensen PJ, Johnson KR, Wheelock MJ: Cross-talk between adherens junctions and desmosomes depends on plakoglobin. J Cell Biol 1997;136:919-934.
82. Hu P, O'Keefe EJ, Rubenstein DS: Tyrosine phosphorylation of human keratinocyte β-catenin and plakoglobin reversibly regulates their binding to E-cadherin and α-catenin. J Invest Dermatol 2001;117:1059-1067.
83. Hu P, Berkowitz P, O'Keefe EJ, Rubenstein DS: Keratinocyte adherens junctions initiate nuclear signaling by translocation of plakoglobin from the membrane to the nucleus. J Invest Dermatol 2003;121:242-251.
84. Hu P, Berkowitz P, Madden VJ, Rubenstein DS: Stabilization of plakoglobin and enhanced keratinocyte cell-cell adhesion by intracellular O-glycosylation. J Biol Chem 2006;281:12786-12791.